The healthcare world is witnessing a significant shift in diabetes management with the introduction of GLP-1 transdermal devices. These systems offer a possibly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The innovation releases the compound directly… Read More